查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947934

马匹保健市场分析及预测（至2035年）：按类型、产品、服务、技术、应用、最终用户、形式、材质、设备和解决方案划分

Equine Healthcare Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Form, Material Type, Device, Solutions
出版日期: | 出版商: Global Insight Services | 英文 315 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，马匹医疗保健市场规模将从2024年的36亿美元成长至65亿美元，复合年增长率约为4.7%。该市场涵盖致力于马匹健康和福祉的产品和服务，例如药品、疫苗、营养补充品和诊断服务。推动市场成长的因素包括马匹疾病发生率上升、马匹数量增加以及兽医技术的进步。关键趋势包括个人化医疗、远端医疗服务和再生医学。对预防保健和性能提升的重视为市场带来了巨大的成长机会。

在兽医学的进步和人们健康意识提升的推动下，马匹医疗保健市场正经历强劲增长。其中，药品领域已成为成长最快的类别，这主要得益于疫苗和疼痛管理解决方案需求的不断增长。营养补充品是成长速度第二快的细分市场，反映出预防医学和提升运动表现的重要性日益凸显。包括先进影像和检测在内的诊断服务发展势头强劲，凸显了早期疾病检测和治疗的重要性。物理治疗和復健等治疗服务也备受关注，以满足老年马匹的需求。马术运动和休閒活动的蓬勃发展进一步推动了对全面医疗保健解决方案的需求。马匹健康监测设备和远距远端医疗的创新提高了医疗服务的可近性和有效性。兽医诊所和製药公司之间的策略合作也为市场扩张提供了支持，这些合作正在开发针对性的治疗通讯协定，并推动个人化医疗保健解决方案的实现。

市场区隔
类型 治疗、诊断、预防保健、復健、营养、手术、急诊和健康计划
产品 药品、疫苗、补充品、医疗设备、手术器材、诊断设备、监测设备
服务 兽医服务、医疗咨询、培训和教育、住院治疗、美容、蹄铁匠服务、復健治疗
科技 远端医疗、穿戴式科技、基因组学、生物技术、奈米技术、诊断影像技术、机器人技术
目的 马匹外科手术、生殖健康、呼吸系统健康、肌肉骨骼健康、消化系统健康、神经系统健康、心血管健康
最终用户 兽医诊所、动物医院、研究机构、育种中心、赛马马厩、骑术中心
形式 片剂、注射剂、粉末、液体、凝胶剂、糊剂、软膏剂
材质 生物製药、合成材料、金属、聚合物、陶瓷
装置 超音波设备、 X光设备、内视镜、核磁共振造影系统、CT扫描仪
解决方案 整合医疗保健解决方案、独立解决方案、客製化解决方案

马匹保健市场正经历动态变化，市场占有率受到创新产品发布和策略定价策略的影响。各公司纷纷推出针对马匹需求的先进保健解决方案，这正在改变市场竞争格局。定价策略日趋复杂，反映出市场对高品质照护和治疗方案的需求不断增长。随着对尖端解决方案的投资持续增加，这一趋势正在推动成熟市场和新兴市场的成长，这些解决方案旨在改善马匹的健康和性能。马匹保健产业的竞争日益激烈，主要参与者相互参考以保持竞争优势。区域法规结构影响产品开发和市场准入，要求企业遵守严格的标准。北美和欧洲拥有强大的监管影响力，制定品质和安全标准。亚太和拉丁美洲等新兴市场由于马匹数量的增长和人们对马匹健康意识的提高，正在创造盈利的市场机会。技术进步和增强竞争力的策略联盟正在推动市场成长。

主要趋势和驱动因素：

在几项关键趋势和驱动因素的推动下，马匹医疗保健市场正经历强劲成长。人们日益增强的动物健康和福利意识是关键驱动因素，马主和育种者越来越重视预防性照护和全面的健康管理。兽医和诊断技术的进步也支持了这一转变，这些技术提高了现有治疗的品质和有效性。马匹医疗保健领域的技术创新，例如穿戴式装置和远端医疗，正在改变产业格局。这些技术能够实现即时监测和远端会诊，从而提高便利性和改善健康状况。此外，马术和休閒活动的日益普及也推动了对更优质医疗保健解决方案的需求，以确保竞技马匹保持最佳状态和延长寿命。同时，对研发投入的增加正在推动新型治疗方法和疫苗的问世，以应对更广泛的马匹疾病。兽医机构和製药公司之间的合作进一步促进了这一趋势，旨在扩大兽医可用的治疗方法。马匹保健市场预计将持续成长，为那些不断创新并适应马匹保健不断变化的需求的公司带来巨大的机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 治疗
    • 诊断
    • 预防医学
    • 復原
    • 营养管理
    • 外科手术
    • 紧急医疗护理
    • 健康计划
  • 市场规模及预测：依产品划分
    • 製药
    • 疫苗
    • 补充
    • 医疗设备
    • 手术器械
    • 诊断设备
    • 监测设备
  • 市场规模及预测：依服务划分
    • 兽医服务
    • 医疗
    • 培训和教育
    • 住院治疗
    • 美容
    • 马蹄铁匠服务
    • 復健治疗
  • 市场规模及预测：依技术划分
    • 远端医疗
    • 穿戴式科技
    • 基因组学
    • 生物技术
    • 奈米科技
    • 诊断影像技术
    • 机器人技术
  • 市场规模及预测：依应用领域划分
    • 马外科手术
    • 生殖健康
    • 呼吸系统健康
    • 肌肉骨骼健康
    • 消化系统健康
    • 神经系统健康
    • 心血管健康
  • 市场规模及预测：依最终用户划分
    • 兽医诊所
    • 兽医诊所
    • 研究所
    • 繁殖中心
    • 赛马马厩
    • 马术中心
  • 市场规模及预测：依类型
    • 药片
    • 注射
    • 粉末
    • 液体
    • 凝胶
    • 贴上
    • 软膏
  • 市场规模及预测：依材质
    • 生物製药
    • 合成
    • 金属
    • 聚合物
    • 陶瓷
  • 市场规模及预测：依设备划分
    • 超音波设备
    • X光设备
    • 内视镜检查
    • 核磁共振造影系统
    • CT扫描仪
  • 市场规模及预测：按解决方案划分
    • 综合医疗保健解决方案
    • 独立解决方案
    • 客製化解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Boehringer Ingelheim Vetmedica
  • Zoetis
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Bimeda
  • Norbrook Laboratories
  • Kyoritsu Seiyaku
  • Phibro Animal Health
  • Huvepharma
  • IDEXX Laboratories
  • Neogen Corporation
  • Animalcare Group
  • Immu Cell Corporation
  • Biogenesis Bago
  • Vetanco
  • Ourofino Saude Animal

第九章：关于我们

简介目录
Product Code: GIS27045

Equine Healthcare Market is anticipated to expand from $3.6 billion in 2024 to $6.5 billion by 2034, growing at a CAGR of approximately 4.7%. The Equine Healthcare Market encompasses products and services dedicated to the health and well-being of horses, including pharmaceuticals, vaccines, nutritional supplements, and diagnostic services. This market is driven by the rising prevalence of equine diseases, increasing horse ownership, and advancements in veterinary technology. Key trends include personalized medicine, telehealth services, and regenerative therapies. The focus on preventive care and performance enhancement offers significant growth opportunities.

The Equine Healthcare Market is experiencing robust growth, propelled by rising awareness and advancements in veterinary care. Within this market, the pharmaceuticals segment emerges as the top-performing category, driven by increased demand for vaccines and pain management solutions. Nutritional supplements follow as the second highest-performing sub-segment, reflecting a growing emphasis on preventive care and performance enhancement. Diagnostic services, including advanced imaging and laboratory testing, are gaining momentum, highlighting the importance of early disease detection and treatment. Therapeutic services, such as physiotherapy and rehabilitation, are also witnessing significant traction, catering to the needs of aging equine populations. The surge in equine sports and leisure activities further fuels demand for comprehensive healthcare solutions. Innovations in equine health monitoring devices and telemedicine are enhancing care accessibility and efficacy. The market's expansion is supported by strategic collaborations between veterinary clinics and pharmaceutical companies, fostering the development of targeted treatment protocols and tailored healthcare solutions.

Market Segmentation
TypeTherapeutics, Diagnostics, Preventive Care, Rehabilitation, Nutrition, Surgery, Emergency Care, Wellness Programs
ProductPharmaceuticals, Vaccines, Supplements, Medical Devices, Surgical Instruments, Diagnostic Equipment, Monitoring Devices
ServicesVeterinary Services, Consultation, Training and Education, Boarding, Grooming, Farrier Services, Rehabilitation Therapy
TechnologyTelemedicine, Wearable Technology, Genomics, Biotechnology, Nanotechnology, Imaging Technology, Robotics
ApplicationEquine Surgery, Reproductive Health, Respiratory Health, Musculoskeletal Health, Gastrointestinal Health, Neurological Health, Cardiovascular Health
End UserVeterinary Clinics, Animal Hospitals, Research Institutes, Breeding Centers, Racing Stables, Equestrian Centers
FormTablets, Injections, Powders, Liquids, Gels, Pastes, Ointments
Material TypeBiologicals, Synthetics, Metals, Polymers, Ceramics
DeviceUltrasound Machines, X-Ray Machines, Endoscopes, MRI Machines, CT Scanners
SolutionsIntegrated Healthcare Solutions, Standalone Solutions, Custom Solutions

The Equine Healthcare Market is experiencing a dynamic shift, with market share being influenced by innovative product launches and strategic pricing approaches. Companies are introducing advanced healthcare solutions tailored to equine needs, which are reshaping competitive dynamics. Pricing strategies are becoming more sophisticated, reflecting the increasing demand for premium care and treatment options. This trend is driving growth in both established and emerging markets, as stakeholders invest in cutting-edge solutions to enhance equine health and performance. Competition within the equine healthcare sector is intensifying, with key players benchmarking against each other to maintain a competitive edge. Regulatory frameworks across regions impact product development and market entry, necessitating compliance with stringent standards. North America and Europe lead in regulatory influence, setting benchmarks for quality and safety. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities, driven by rising equine populations and increasing awareness of equine health. The market is poised for growth, with technological advancements and strategic partnerships enhancing competitive positioning.

Geographical Overview:

The equine healthcare market is witnessing robust growth across various regions, each presenting unique opportunities. North America leads, driven by a high prevalence of equine diseases and substantial investments in veterinary healthcare. The region's advanced healthcare infrastructure and a strong equestrian culture further bolster market expansion. Europe follows, with countries like Germany and France investing heavily in equine health research and equine welfare initiatives. The Asia Pacific region is experiencing rapid growth, propelled by increasing awareness of equine health and rising disposable incomes. Countries such as China and India are emerging as key markets, with growing equestrian sports and leisure activities. Latin America and the Middle East & Africa are also showing potential, with increasing government support for veterinary services and equine welfare. Brazil and the UAE are notable emerging markets, recognizing the importance of equine healthcare in supporting their thriving equestrian industries.

Tariffs and geopolitical tensions are significantly impacting the Equine Healthcare Market, especially in East Asia. Japan and South Korea are navigating trade barriers by enhancing local production capabilities and fostering innovation in equine pharmaceuticals and diagnostics. China, amidst geopolitical strains, is investing in self-sufficiency and expanding its equine healthcare infrastructure. Taiwan, while a pivotal player in high-tech veterinary equipment, faces geopolitical vulnerabilities. The global equine healthcare market is witnessing steady growth, driven by rising equine sports and leisure activities. By 2035, market evolution will hinge on strategic partnerships and supply chain resilience. Middle East conflicts are indirectly influencing the market, as fluctuations in energy prices affect transportation and manufacturing costs, necessitating adaptive strategies in these Asian markets.

Key Trends and Drivers:

The equine healthcare market is experiencing robust growth, propelled by several key trends and drivers. Rising awareness of animal health and welfare is a primary driver, as owners and breeders increasingly prioritize preventative care and comprehensive health management for their horses. This shift is supported by advancements in veterinary medicine and diagnostics, which are enhancing the quality and efficacy of treatments available. Technological innovations in equine healthcare, such as wearable devices and telemedicine, are transforming the industry landscape. These technologies enable real-time monitoring and remote consultations, providing convenience and improved health outcomes. Additionally, the growing popularity of equestrian sports and recreational activities is fueling demand for superior healthcare solutions to ensure peak performance and longevity of equine athletes. Moreover, increased investment in research and development is fostering the introduction of novel therapeutics and vaccines, addressing a broader range of equine diseases. This trend is further driven by collaborations between veterinary institutions and pharmaceutical companies, aiming to expand the therapeutic arsenal available to veterinarians. The equine healthcare market is poised for sustained growth, with significant opportunities for companies that innovate and adapt to the evolving needs of equine health management.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by Material Type
  • 2.9 Key Market Highlights by Device
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Therapeutics
    • 4.1.2 Diagnostics
    • 4.1.3 Preventive Care
    • 4.1.4 Rehabilitation
    • 4.1.5 Nutrition
    • 4.1.6 Surgery
    • 4.1.7 Emergency Care
    • 4.1.8 Wellness Programs
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Pharmaceuticals
    • 4.2.2 Vaccines
    • 4.2.3 Supplements
    • 4.2.4 Medical Devices
    • 4.2.5 Surgical Instruments
    • 4.2.6 Diagnostic Equipment
    • 4.2.7 Monitoring Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Veterinary Services
    • 4.3.2 Consultation
    • 4.3.3 Training and Education
    • 4.3.4 Boarding
    • 4.3.5 Grooming
    • 4.3.6 Farrier Services
    • 4.3.7 Rehabilitation Therapy
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Telemedicine
    • 4.4.2 Wearable Technology
    • 4.4.3 Genomics
    • 4.4.4 Biotechnology
    • 4.4.5 Nanotechnology
    • 4.4.6 Imaging Technology
    • 4.4.7 Robotics
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Equine Surgery
    • 4.5.2 Reproductive Health
    • 4.5.3 Respiratory Health
    • 4.5.4 Musculoskeletal Health
    • 4.5.5 Gastrointestinal Health
    • 4.5.6 Neurological Health
    • 4.5.7 Cardiovascular Health
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Veterinary Clinics
    • 4.6.2 Animal Hospitals
    • 4.6.3 Research Institutes
    • 4.6.4 Breeding Centers
    • 4.6.5 Racing Stables
    • 4.6.6 Equestrian Centers
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Tablets
    • 4.7.2 Injections
    • 4.7.3 Powders
    • 4.7.4 Liquids
    • 4.7.5 Gels
    • 4.7.6 Pastes
    • 4.7.7 Ointments
  • 4.8 Market Size & Forecast by Material Type (2020-2035)
    • 4.8.1 Biologicals
    • 4.8.2 Synthetics
    • 4.8.3 Metals
    • 4.8.4 Polymers
    • 4.8.5 Ceramics
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Ultrasound Machines
    • 4.9.2 X-Ray Machines
    • 4.9.3 Endoscopes
    • 4.9.4 MRI Machines
    • 4.9.5 CT Scanners
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Healthcare Solutions
    • 4.10.2 Standalone Solutions
    • 4.10.3 Custom Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Form
      • 5.2.1.8 Material Type
      • 5.2.1.9 Device
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Form
      • 5.2.2.8 Material Type
      • 5.2.2.9 Device
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Form
      • 5.2.3.8 Material Type
      • 5.2.3.9 Device
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Form
      • 5.3.1.8 Material Type
      • 5.3.1.9 Device
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Form
      • 5.3.2.8 Material Type
      • 5.3.2.9 Device
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Form
      • 5.3.3.8 Material Type
      • 5.3.3.9 Device
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Form
      • 5.4.1.8 Material Type
      • 5.4.1.9 Device
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Form
      • 5.4.2.8 Material Type
      • 5.4.2.9 Device
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Form
      • 5.4.3.8 Material Type
      • 5.4.3.9 Device
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Form
      • 5.4.4.8 Material Type
      • 5.4.4.9 Device
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Form
      • 5.4.5.8 Material Type
      • 5.4.5.9 Device
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Form
      • 5.4.6.8 Material Type
      • 5.4.6.9 Device
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Form
      • 5.4.7.8 Material Type
      • 5.4.7.9 Device
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Form
      • 5.5.1.8 Material Type
      • 5.5.1.9 Device
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Form
      • 5.5.2.8 Material Type
      • 5.5.2.9 Device
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Form
      • 5.5.3.8 Material Type
      • 5.5.3.9 Device
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Form
      • 5.5.4.8 Material Type
      • 5.5.4.9 Device
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Form
      • 5.5.5.8 Material Type
      • 5.5.5.9 Device
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Form
      • 5.5.6.8 Material Type
      • 5.5.6.9 Device
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Form
      • 5.6.1.8 Material Type
      • 5.6.1.9 Device
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Form
      • 5.6.2.8 Material Type
      • 5.6.2.9 Device
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Form
      • 5.6.3.8 Material Type
      • 5.6.3.9 Device
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Form
      • 5.6.4.8 Material Type
      • 5.6.4.9 Device
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Form
      • 5.6.5.8 Material Type
      • 5.6.5.9 Device
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Boehringer Ingelheim Vetmedica
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Zoetis
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Merck Animal Health
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Elanco Animal Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Ceva Sante Animale
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Virbac
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Vetoquinol
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Dechra Pharmaceuticals
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Bimeda
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Norbrook Laboratories
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Kyoritsu Seiyaku
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Phibro Animal Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Huvepharma
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 IDEXX Laboratories
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Neogen Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Animalcare Group
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Immu Cell Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biogenesis Bago
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Vetanco
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ourofino Saude Animal
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us